Cost transformation for growth (or CTG) is Stryker’s program that focuses on driving leveraged growth by structural cost optimization.
Most of Stryker’s emerging market sales are from China. However, Europe and emerging markets sales have witnessed high growth in recent quarters.
In March 2017, Stryker (SYK) announced the commercial launch of its robotic-arm assisted total knee application to be used with its MAKO system.
At the end of 1Q17, Stryker had placed 350 robots in the United States and completed about 1,400 MAKO total knee replacements.
In a Reuters survey of 27 brokerage companies, about 63.0% of analysts have rated Stryker a “buy,” and 26.0% have rated it a “hold.”
In January 2017, Medtronic received FDA IDE approval to initiate a study of its IN.PACT AV Access DCB for a new indication in ESRD patients.
On June 6, 2017, Medtronic (MDT) received the Health Canada license for its SureTune3 software for DBS (deep brain stimulation) therapy.
On June 13, 2017, Baker Hughes’s (BHI) implied volatility was 20.3%.
On June 13, BHI’s stock price rose 2% over its previous day’s close. GE’s stock price reaction was lukewarm with a fall 2% on June 13.
On April 18, Medtronic announced the divestiture of its Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses to Cardinal Health.
According to a recent report from The Capital Forum, the FTC is set to block the pending merger of Walgreens Boots Alliance (WBA) and Rite Aid (RAD).
Medtronic’s (MDT) Tyrx envelope is an antibacterial and fully-absorbable device that helps prevent surgical site infections.
On June 7, 2017, Medtronic (MDT) announced the launch of MiniMed 670G—the world’s first HCL (hybrid closed loop) insulin delivery system.
VMware isn’t the only company that invested first and bought later. In late 2016, IBM (IBM) acquired Fluid’s Expert Personal Shopper (or XPS) division, in which it had invested in the past.
Apteligent’s technology will provide VMW’s IT (information technology) department with improved visibility and will address mobile performance problems more swiftly.
It seems that like Microsoft (MSFT), VMware has adopted an acquisitions strategy to scale up and enhance its reach in the concentrated and competitive cloud space.
In March 2017, Imagination revealed that Apple will stop using its graphics cards over the next two years. Instead, Apple will use graphics cards developed in-house.
The contract manufacturers don’t intend to withhold royalty payments, but they aren’t getting the cash from Apple.
On May 15, 2017, Thermo Fisher (TMO) announced the acquisition of Patheon (PTHN) for ~$7.2 billion, which includes ~$2 billion of net debt assumption.
In 1Q17, ~8% of TMO’s total 11% YoY revenue growth was contributed by the company’s recent acquisitions.